United Guardian UG
NASDAQ UG
$7.13 +0.01 (+0.07%)
As of: Sep 9, 2026 · 1:24 PM EDT

United Guardian (UG) Non-Current Deferred Tax Liability (2010 - 2026)

United Guardian's (UG) quarterly Non-Current Deferred Tax Liability came in at $224351.0 in Q2 2026, up 186.51% year-over-year from $78306.0 in Q2 2025, and down 32.11% quarter-over-quarter from $330482.0 in Q1 2026.

Analysis

United Guardian (UG) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

United Guardian has disclosed Non-Current Deferred Tax Liability across 17 years of filings, most recently posting $224351.0 for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability rose 186.51% year-over-year to $224351.0; the TTM figure through Jun 2026 stood at $224351.0 (up 186.51% YoY), while the FY2025 annual figure was $207246.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability came in at $224351.0 for Q2 2026 at United Guardian, down from $330482.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $330482.0 in Q1 2026 to a low of $19639.0 in Q1 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $142225.5, with a median of $138091.5 recorded in 2022.
  • Year-over-year, Non-Current Deferred Tax Liability sank 89.41% in 2022 and jumped 186.51% in 2026.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $31903.0 in 2022, then surged by 50.46% to $48000.0 in 2023, then plunged by 59.09% to $19639.0 in 2024, then soared by 955.28% to $207246.0 in 2025, then increased by 8.25% to $224351.0 in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $224351.0 in Q2 2026, $330482.0 in Q1 2026, and $207246.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn
7 Revolution Medicines 44.21 Bn 44.21 Bn -
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn
10 United Guardian 32.97 Mn 23.37 Mn 1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 224,351.00
Mar 31, 2026 330,482.00
Dec 31, 2025 207,246.00
Jun 30, 2025 78,306.00
Mar 31, 2024 19,639.00
Sep 30, 2023 48,000.00
Jun 30, 2022 31,903.00
Mar 31, 2022 197,877.00
Dec 31, 2021 83,222.00
Sep 30, 2021 227,203.00
Jun 30, 2021 301,138.00
Mar 31, 2021 213,677.00
Dec 31, 2020 151,684.00
Sep 30, 2020 231,728.00
Jun 30, 2020 124,846.00
Mar 31, 2020 302,843.00
Dec 31, 2019 386,855.00
Sep 30, 2019 234,736.00
Jun 30, 2019 208,511.00
Mar 31, 2019 264,439.00